Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition

Maturitas

Volumn 75, Issue 2, 2013, Pages 170-174

  Freeman, Marlene P ^a   Hirschberg, April M ^a   Wang, Betty ^a   Petrillo, Laura F ^a   Connors, Stephanie ^a   Regan, Susan ^a   Joffe, Hadine ^a   Cohen, Lee S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anxiety; Depression; Hot flashes; Major depressive disorder; Menopause; Vasomotor symptoms

Indexed keywords

DULOXETINE; PLACEBO;

ACNE; ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EPISTAXIS; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HEART PALPITATION; HOT FLUSH; HUMAN; MAJOR DEPRESSION; MYALGIA; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; REMISSION; SIDE EFFECT; SWEATING; TREMOR;

ANTIDEPRESSIVE AGENTS; ANXIETY; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; THIOPHENES;

EID: 84877829491     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.03.007     Document Type: Article

References (32)

1. N. Avis, D. Brambilla, S. McKinlay, and K. Vass A longitudinal analysis of the association between menopause and depression: results from the Mass, Women's Health Study Annals of Epidemiology 4 1994 214 220
2. H. Joffe, J. Hall, and C. Soares Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care Menopause 9 November-December (6) 2002 392 398
3. L.S. Cohen, C.N. Soares, and A.F. Vitonis Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles Archives of General Psychiatry 63 April (4) 2006 385 390
4. M.M. Weissman, P.J. Leaf, and C.E. Holzer The epidemiology of depression. An update on sex differences in rates Journal of Affective Disorders 7 December (3-4) 1984 179 188
5. R.C. Kessler Epidemiology of women and depression Journal of Affective Disorders 74 March (1) 2003 5 13
6. E.W. Freeman, M.D. Sammel, and H. Lin Associations of hormones and menopausal status with depressed mood in women with no history of depression Archives of General Psychiatry 63 April (4) 2006 375 382
7. J.T. Bromberger, S.F. Assmann, and N.E. Avis Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women American Journal of Epidemiology 158 August (4) 2003 347 356
8. E.W. Freeman, M.D. Sammel, and H. Lin The role of anxiety and hormonal changes in menopausal hot flashes Menopause 12 May-June (3) 2005 258 266
9. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 July (3) 2002 321 333
10. S.G. Kornstein, Q. Jiang, and S. Reddy Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder Journal of Clinical Psychiatry 71 August (8) 2010 1088 1096
11. E.W. Freeman, K.A. Guthrie, and B. Caan Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial JAMA 305 January (3) 2011 267 274
12. H. Joffe, C.N. Soares, and L.F. Petrillo Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine Journal of Clinical Psychiatry 68 June (6) 2007 943 950
13. H. Joffe, H. Groninger, and C.N. Soares An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy Journal of Women's Health and Gender-Based Medicine 10 December (10) 2001 999 1004
14. C.N. Soares, J.R. Poitras, and J. Prouty Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms Journal of Clinical Psychiatry 64 April (4) 2003 473 479
15. C.N. Soares, M.E. Thase, and A. Clayton Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder Menopause 17 July (4) 2010 700 711
16. P.R. Gordon, J.P. Kerwin, and K.G. Boesen Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population Menopause 13 July-August (4) 2006 568 575
17. V. Stearns Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms Treatments in Endocrinology 5 2 2006 83 87
18. G. Rada, D. Capurro, and T. Pantoja Non-hormonal interventions for hot flushes in women with a history of breast cancer Cochrane Database of Systematic Reviews 9 2010 CD004923
19. M.R. Soules, S. Sherman, and E. Parrott Executive summary: Stages of Reproductive Aging Workshop (STRAW) Fertility and Sterility 76 5 2001 874 878
20. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery and Psychiatry 23 1960 56 62
21. H. Joffe, L.F. Petrillo, and A. Koukopoulos Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition Journal of Clinical Endocrinology and Metabolism 96 July (7) 2011 E1044 E1054 10.1210/jc.2010-2503
22. J.A. Sloan, C.L. Loprinzi, and P.J. Novotny Methodologic lessons learned from hot flash studies Journal of Clinical Oncology 19 23 2001 4280 4290
23. J.S. Carpenter The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer Journal of Pain and Symptom Management 22 December (6) 2001 979 989
24. M.H. Blatt, H. Wiesbader, and H.S. Kupperman Vitamin E and climacteric syndrome; failure of effective control as measured by menopausal index AMA Archives of Internal Medicine 91 June (6) 1953 792 799
25. W. Guy ECDEU assessment manual for psychopharmacology. US Dept Health, Education, and Welfare Publication (ADM) 76-338 1976 National Institute of Mental Health Rockville, Maryland 218 222
26. Handbook of psychiatric measures First ed. 2000 American Psychiatric Association Washington, DC
27. S.D. Reed, E.J. Ludman, and K.M. Newton Depressive symptoms and menopausal burden in the midlife Maturitas 62 March (3) 2009 306 310
28. H. Joffe, L. Petrillo, and A. Viguera Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial American Journal of Obstetrics and Gynecology 202 February (2) 2010 171.e1 171.e11
29. H. Joffe, A. Partridge, and A. Giobbie-Hurder Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial Menopause 17 September-October (5) 2010 908 916
30. J.E. Desmarais, and K.J. Looper Interactions between tamoxifen and antidepressants via cytochrome P450 2D6 Journal of Clinical Psychiatry 70 December (12) 2009 1688 1697
31. C.B. Nemeroff, C.L. DeVane, and B.G. Pollock Newer antidepressants and the cytochrome P450 system American Journal of Psychiatry 153 March (3) 1996 311 320
32. C.M. Kelly, D.N. Juurlink, and T. Gomes Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study British Medical Journal 340 2010 c693